至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence

Front Immunol. 2024-02; 
Lorenzo Federico, Brandon Malone, Simen Tennøe, Viktoriia Chaban, Julie Røkke Osen, Murat Gainullin, Eva Smorodina, Hassen Kared, Rahmad Akbar, Victor Greiff, Richard Stratford, Trevor Clancy, Ludvig Andre Munthe
Products/Services Used Details Operation
Catalog Peptides “Peptides were synthesized by GenScript (Piscataway, NJ, USA) at a purity≥ 85%, and used at a final concentration of 1.5 mg/mL each.” The corrected sentence appears below:“… Get A Quote

摘要

[This corrects the article DOI: 10.3389/fimmu.2023.1265044.].

关键词

CD4+ lymphocytes, CD8+ lymphocytes, COVID-19, SARS-CoV-2, T cell, antigen (Ag), artificial intelligence, vaccine